AI in drug development: advances in response,combination therapy, repositioning, and molecular design

摘要

Artificial intelligence(AI) is revolutionizing the field of drug development, particularly in addressing key challenges such as drug response prediction, drug combination design, drug repositioning, and drug molecule generation. Traditional drug discovery is hindered by long timelines, high costs, and low success rates, necessitating innovative technologies to accelerate the process. AI technologies, such as deep learning, graph neural networks, and generative models, have demonstrated significant potential in enhancing the accuracy of drug response predictions, optimizing drug combination strategies,identifying opportunities for drug repositioning, and generating drug molecules with specific biological activities. These advancements not only accelerate the drug development process but also open up new possibilities for precision medicine.This review discusses the latest applications and developments of AI in drug discovery, highlighting the breakthroughs and challenges AI addresses in drug development. By summarizing the current research progress, this study provides theoretical support and practical guidance for further applications of AI in drug development.